GlaxoSmithKline Pushing Dangerous Avandia Drug on Thousands in New Global Clinical Trial

Back in February, I wrote an article about how a Senate Finance Committee report revealed that GlaxoSmithKline, the maker of the diabetes drug Avandia, knew that its drug was dangerous and caused heart attacks; yet GSK went out of its way to hide this important information from the public and kept on selling Avandia. Now, GSK has now decided to launch a global clinical trial of this dangerous drug that could potentially harm thousands of people.

Both FDA and GSK scientists have found that Avandia is dangerous and significantly increases the risk of heart attacks, but the drug remains on the market to this day. FDA officials have rejected sound scientific evidence demonstrating the dangers of the drug, including evidence from the FDA's own scientists.'

Read more...